4//SEC Filing
Bedrosian Camille L 4
Accession 0000950170-24-111809
CIK 0001658551other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 6:50 PM ET
Size
5.1 KB
Accession
0000950170-24-111809
Insider Transaction Report
Form 4
Bedrosian Camille L
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-09-30$3.20/sh−11,442$36,559→ 143,801 total
Footnotes (2)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.125 to $3.24. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Documents
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeother
Related Parties
1- filerCIK 0001326969
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 6:50 PM ET
- Size
- 5.1 KB